Masonic Cancer Center, University of Minnesota: Hematologic Neoplasms trials
The registry lists 12 Hematologic Neoplasms studies with Masonic Cancer Center, University of Minnesota as lead sponsor. 2 are open to participants now and 7 have results posted.
Phase 1 3Phase 2 7Phase 3 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme MalignanciesRecruitingNCT05735717Phase 2
- Infusion of Cell Populations From Unlicensed Umbilical Cord Blood UnitsRecruitingNCT01451502Not applicable
- Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCTCompletedNCT02988466Phase 2Results posted
- Pilot Study of Multi-Modality Imaging in Patients With Hematologic MalignanciesTerminatedNCT02042924Not applicableResults posted
- IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCTCompletedNCT01885897Phase 1/2Results posted
- Influenza Vaccine Post Allogeneic TransplantTerminatedNCT01215981Not applicableResults posted
- Study of Immune Response Modifier in the Treatment of Hematologic MalignanciesTerminatedNCT00276159Phase 2Results posted
- Stem Cell Transplant for Hematological MalignancyTerminatedNCT00176930Not applicableResults posted
- Stem Cell Transplantation for Hematological MalignanciesTerminatedNCT00176839Phase 2/3Results posted
- Treg Cells for AGVHD in Non-myeloablative UCB TransplantWithdrawnNCT02118311Phase 2
- Safety of Romiplostim (Nplate®) Following UCBTCompletedNCT02046291Phase 1
- T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic MalignanciesWithdrawnNCT01163201Phase 1/2